-+ 0.00%
-+ 0.00%
-+ 0.00%

Freedom Capital Markets Initiates Coverage On Sionna Therapeutics with Buy Rating, Announces Price Target of $38

Benzinga·10/17/2025 19:02:29
Listen to the news
Freedom Capital Markets analyst Ilya Zubkov initiates coverage on Sionna Therapeutics (NASDAQ:SION) with a Buy rating and announces Price Target of $38.